See the difference in frown lines before and after treatment with XEOMIN®
Individual results may vary. Unretouched photos.
Julie, Age 45
Severe Glabellar Frown Lines
The median first onset of XEOMIN® effect occurs within 7 days of injection. Maximum effect occurs at 30 days. The typical duration of effect is up to 3 months, but may last significantly longer or shorter in individual patients. In studies, XEOMIN®-treated subjects ranged from 24 to 74 years of age with an average age of 46.
Individual results may vary. Unretouched photos.
Derek, Age 41
Moderate Glabellar Frown Lines
The median first onset of XEOMIN® effect occurs within 7 days of injection. Maximum effect occurs at 30 days. The typical duration of effect is up to 3 months, but may last significantly longer or shorter in individual patients. In studies, XEOMIN®-treated subjects ranged from 24 to 74 years of age with an average age of 46.
What is XEOMIN®?
XEOMIN® is a prescription medication used in facial aesthetics to temporarily improve the appearance of moderate to severe glabellar frown lines between the eyes (glabellar lines) in adults.
XEOMIN® contains botulinum toxin type A, a protein purified from the bacterium Clostridium botulinum.
XEOMIN® is also sometimes referred to as incobotulinumtoxinA.
XEOMIN® in Aesthetics: How Does it Work?
When you squint or frown, the muscles between your brows contract, causing the skin to furrow and fold. These lines that occur due to facial mimics are referred to as dynamic lines. Over time, as your skin ages and loses some of its elasticity, these repeated contractions can cause persistent frown lines.
Botulinum toxin type A – the active ingredient in XEOMIN® – is used in facial aesthetic treatment to treat dynamic lines like glabellar frown lines. It acts on nerve endings in muscles to prevent muscle fibers from contracting. By reducing these contractions, XEOMIN® can temporarily reduce the frown lines on your forehead between your eyes.
